This review provides a comparative analysis of sugar substitutes – from classic polyols and intense sweeteners to promising rare sugars and recombinant sweet proteins. Their natural sources, industrial production methods, and metabolism in the human body are examined. Data on benefits and proven/potential risks are systematized. A conclusion is drawn regarding the shift from the empirical use of sugar substitutes to personalized nutrition based on molecular risk profiling
No takes yet. Share an insight, caveat, or question.
Larisa Fomina (2026) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: